Loading article...
Loading article...
Stream/Area:
-
Subject:
-
Paper ID:
10.55041/IJSREM25179
Volume:
7 |
8 |
Aug 2023
Pages:
Publication Frequency:
Monthly (12 issues per year)
License:International Journal of Scientific Research in Engineering and Management follows the Creative Commons Attribution 4.0 (CC BY 4.0) License, allowing free use and distribution with proper attribution.
Nanoparticle-based drug delivery systems have emerged as promising tools in cancer therapy, offering enhanced precision and effectiveness in targeting tumor cells while minimizing damage to healthy tissues. This review provides a comprehensive exploration of the tumor microenvironment, emphasizing its critical role in cancer progression. It highlights the significance of targeted drug delivery in improving treatment outcomes and introduces nanoparticle-based delivery systems as innovative strategies to address these challenges. The first section delves into various types of nanoparticles used for tumor targeting. Liposomes, known for their versatility and biocompatibility, are discussed alongside examples of liposome-based drug delivery systems tailored for tumor-specific applications. Polymeric nanoparticles, employing a range of polymers, offer unique advantages and applications in tumor targeting. Metallic nanoparticles, with distinctive properties, have shown promise in drug delivery systems designed to target tumors effectively. The design considerations for tumor targeting form the core of the third section. Passive targeting exploits the Enhanced Permeability and Retention (EPR) effect, and strategies to enhance this approach using nanoparticles are explored. Active targeting methods, involving ligand-mediated and biomarker-specific approaches, are detailed. Additionally, combination strategies and stimulus-responsive drug release systems are examined for their potential synergistic effects in improving tumor targeting. The challenges and opportunities associated with nanoparticle-based drug delivery systems are outlined in the fourth section. Overcoming physiological barriers, optimizing drug release kinetics, and ensuring safety and biocompatibility are key concerns addressed in this section. Strategies to bypass systemic clearance and immune responses, achieve controlled drug release, and enhance biocompatibility are discussed in depth. The review also del
KEYWORDS
Publication Date
10/7/2023
Peer Review Type
Double-Blind Peer Review
Review Rounds: 2
Documents
Article Views
0
Total views since publication
PDF Downloads
2
Total downloads since publication
Geographic Reach
5
Digital Preservation: This article is permanently archived on Zenodo and complies with all data preservation standards across major indexing platforms.
Plagiarism Screening
This manuscript has been checked for plagiarism using TurnitinPlagiarismChecker software.
Conflict of Interest
The authors declare no conflict of interest related to this research work.
Funding Information
No funding information available for this research.
Related research in the same subject area
Loading similar articles...